Two Nicotine Addiction Vaccines On Phase III Racetrack
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis partners with Cytos on CYT002-NicQb, while Nabi looks to partner NicVax prior to pivotal trials in second half.